Evaluation Of Risk Factors and Biological Markers Related To Oral Epithelial Dysplasia and Squamous Cell Carcinoma: Case Control Study
Rabab I Salama1*, Amal El Deeb2, Hoda A Fansa3
1 Assistant Professor of Dental Public Health and Preventive Dentistry, Faculty of Dentistry, Mansoura University.
2 Professor of Oral Pathology, Faculty of Dentistry, Tanta University, Tanta, Egypt. Affiliated to Faculty of Dentistry, Umm Al Qura University, Makkah,
KSA.
3 Assistant professor of Oral Biology, Faculty of Dentistry, Alexandria University.
*Corresponding Author
Rabab I Salama,
Assistant Professor of Dental Public Health and Preventive Dentistry, Faculty of Dentistry, Mansoura University.
Tel: 00966543921432
Fax: 0543921432
Email Id: sad2_4@yahoo.com
Received: April 17, 2021; Accepted: May 22, 2021; Published: May 30, 2021
Citation: Rabab I Salama, Amal El Deeb, Hoda A Fansa. Evaluation Of Risk Factors and Biological Markers Related To Oral Epithelial Dysplasia and Squamous Cell Carcinoma:
Case Control Study. Int J Dentistry Oral Sci. 2021;08(05):2671-2679.doi: dx.doi.org/10.19070/2377-8075-21000522
Copyright: Rabab I Salama©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution
and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: Oral squamous cell carcinoma is recognized as a public health concern worldwide. It is the sixth most common
malignancy which recorded 90% of all oral malignant tumors causing a significant number of cancer related death every year.
The late diagnosis and lack of specific biomarkers for predicting the tumor progression and patient's prognosis could be the
cause of the high mortality rate.
Objectives: To assess the oral epithelial dysplasia and squamous cell carcinoma (OSCC) risk factors and evaluate immunohistochemically
the over expression of P53 in cases of oral epithelial dysplasia and OSCC and correlate it with the expression of
the immune cell in?ltrate (CD4 and CD8) in the same lesions.
Methodology: A case control study was conducted on (25) cases of oral epithelial dysplasia and (35) case with oral squamous
cell carcinoma compared with (240) participants as a control group who was matched with age gender and smoking status.
Data were collected by interview administrated questionnaire, clinical examination and immunohistochemistry. The immunohistochemistry
was done on (60) samples from cases and (60) randomly samples from control group.
Results: Smoking, oral hygiene practice and periodontal conditions considered risk factors for oral cancer. The expression of
CD4+ and CD8+ was increased with the transformation from normal epithelium to dysplastic epithelium and squamous cell
carcinoma, this expression was significantly correlated with P53 immunostaining at p (< 0.000).
Conclusion: The most detected risk factors related to OSCC were the frequency and duration of smoking, bad oral hygiene,
sever periodontitis and low educational level. Public awareness is needed among these targeted groups to prevent oral cancer.
The increase in the expression of CD4+, CD8 + with epithelial transformation from normal to dysplastic or squamous cell
carcinoma and its correlation with the over expression of P53 may have a potential significant role as biological markers of
malignant transformation and carcinogenesis, and it could potentially be utilized in the treatment of oral squamous cell carcinoma.
2.Introduction
3.Materials and Methods
4.Results
5.Discussion
6.Conclusion
7.References
Keywords
Epithelial Dysplasia; Oral Squamous Cell Carcinoma; P53; Cd4; Cd8.
Introduction
The oral squamous cell carcinoma is recognized as a public health
concern worldwide. It is the sixth most common malignancy
which account 90% of all oral malignancies causing a significant
number of cancer related death every year [1]. Assessment of future
preventive strategies is of high clinical relevance. This could
lead to the recognition of the pre-malignant oral lesions and its
malignant transformation at initial stages with a positive impact
on the outcome. The etiology of oral squamous cell carcinoma
is multi- factorial; genetic, environment, social and behavioral effects may all be implicated [2].
Regarding the etiological factors, smoking consumption is widely
recognized as major risk factor for oral malignancies [3]. Previous
epidemiological studies have provided evidence of the effect of
oral health status and oral hygiene practices on the development
of oral malignancies. Poor oral hygiene seems to cause additional
oral cancer risks. Irregular toothbrushing, dental prostheses, and
use of oral hygiene measures have all been associated with development
of oral cancer [4, 5].
Higher proportion of cases of OSCC develop from premalignant
lesions such as leukoplakia. The late diagnosis and lacking of specific
predictive biomarkers for tumor progression and patient's
prognosis could be the cause of the high mortality rate of OSCC
[6-8].
The histological tissue examination is the gold standard for diagnosis
of the malignant transformation of oral lesions. One of the
fundamentals in reducing the cost of treatment, and high morbidity
associated with OSCC is the identification of high-risk oral
premalignant lesions. Molecular biological markers evaluation was
recorded as avery useful methods in the diagnosis and prognostic
evaluation of premalignantlesions [6].
The cancerization process is attributed to clinical, molecular and
immunological factors, immune system and cancer are mutually
related as tumors development are potentially immunogenic [9].
Studies of the cancer-immune system interactions have revealed
that every known innate and adaptive immune effector mechanism
aids in the tumor recognition and control process [10]. Adaptive
immunity's effectors such as CD4+ helper T cells, CD8+ cytotoxic
T cells, and antibodies are speci?cally targeted the tumor
antigens. Tumor antigens are molecules expressed only in tumor
cellsare normal cellular proteins that are abnormally expressed as
a result of genetic mutations, quantitative differences in expression,
or differences in post translational modi?cations [10].
The immune suppression, both systemically and at the site of the
tumor is a characteristic feature of squamous cell carcinoma of
head and neck (SCCHN) patients. Increased levels of circulating
T regulatory cells and CD34+ progenitor cells have been shown
to suppress CD8+ T cell-mediated immunity and are associated
with a poorer prognosis [11, 12]. There is also evidence that premalignant
lesions are characterized by an influx of proinflammatory
immune cells, including NK cells, macrophages, and CD8+
T cells and that CD8+ T cells are more activated in premalignant
oral tissue [13, 14].
Multiple proto-oncogenes and tumor suppressor genes including
p16, cyclin D1, P53 and EGFR are involved in the oral carcinogenesis
process. P53 is a tumor suppressor gene located on chromosome
17p. Mutations of P53 gene is one of the most common
events in human carcinogenesis. As mutated protein is not easily
digestible, therefore it accumulates inside the cancer cell resulting
in immunohistochemical over expression. In OSCC, over expression
of P53 is considered a marker of poor prognosis and may
result in decreased sensitivity of tumor cells to chemotherapeutic
drugs [6, 9].
Many studies reported that, up to 75% of oral squamous carcinoma
could be prevented by avoiding environmental factors, particularly
the consumption of tobacco and improved diagnostic
methods [2-8]. Therefore, this study aimed to assess the epithelial
dysplasia and OSCC risk related factors and evaluate immunohistochemically
over expression of P53 in cases of oral epithelial
dysplasia and OSCC andcorrelate it with the expression of the
immune cell in?ltrate (CD4 and CD8) in the same lesions.
Materials and Methods
Case's Selection
The present study was designed as case control study on patient
with epithelial dysplasia or with oral squamous cell carcinomarecruited
from two oncology centers (Tanta cancer institute and
Damietta Oncology Center) and from oral surgery and oral pathology
department, faculty of dentistry, Tanta university. All the
medical records of patients with epithelial dysplasia or with oral
squamous cell carcinoma (OSCC) were revised and the freshly diagnosed
cases (at the late three months) with contact phone number
or address were selected to be included in the study. Only (60)
patients, (26) female patients and (34) male patients who signed
informed consent and approved to use their data, were included
in this study.
Control's Selection
The control participants were selected from the out-patient’s
clinic, Damietta General Hospital. A total of (240) patients who
approved to participate in this study, were recruited with matching
procedure by age, gender, and smoking habits which was done to
finalize the selection of the control group. Control participants
with systemic diseases or with oral premalignant or malignant lesions
or any type of cancer were excluded. The control group after
matching procedure were consists of: (64) female participants
with and age range from 40 - 60 years, non-smokers, (61) male
participants, non - smokers with and age ranged from 40 - 80
years and (115) smoker males with and age ranged from 40 - 80
years.
Data Collection
Data was collected by interviewer administrated questionnaire,
reviewed patients' medical records, clinical examination and immunohistochemical
examination.
Before starting the study, the questionnaire was piloted to (20)
participants from the cases and control groups and some modifications
to it was performed according to the feedback. Thequestionnaire
was applied to all cases and control participants by
face-to-face interview. The questionnaire included data about the
demographic characters in addition to smoking habits and its duration
and oral hygiene practice measures. Data related to the epithelial
dysplasia histological grade, oral squamous cell carcinoma
clinical site or stage, lymph node metastasis or distant metastasis
were recorded from the medical records.
The Clinical Examination: To ensure the validity of clinical examination
data, one examiner was trained and calibrated for all examined
clinical criteria. The examiner who was blind to differentiated
between the cases and the controls, examined dental and oral
status for all participants, the presence of oral fixed or removable prosthodontics appliance were recorded. Periodontal conditions
and teeth mobility were evaluated by Russell index [15].
Tissue Blocks Preparation: Sixty paraffin embedded lesions
previously diagnosed as epithelial dysplasia (25) and OSCC (35)
were examined after ethical approval from the patients. Newly
prepared (60) paraffin embedded healthy tissue from the control
patients (24 from females and 36 from males) were prepared after
approval from the patients.
Immunohistopathological Examination: From each paraffin-embedded
block 5µm thick sections were cut and routinely
stained with H&E (Hematoxylin and Eosin), then analyzed using
light microscopy to confirm the diagnosis. Two independent
oral pathologists examined the stained sections and determine
histological grades of epithelial dysplasia (Mild, moderate and severe
dysplasia) according to World Health Organization (WHO)
criteria, similarly, OSCC cases were examined and differentiated
histologically in to (poorly, moderate and well differentiated) [16].
Immunostaining: Paraffin-embedded biopsies were cut in to
4µm thick sections. The sections were mounted on recharged
slides, deparaffinized, and rehydrated. Antigen retrieval was performed
by placing the slides in citrate buffer at 95°C for 5 minutes
(4-5 times). Then the slides were cooled to room temperature.
Washing the slides with wash buffer (phosphate buffer solution,
PBS,), then block the slides with (0.3% hydrogen peroxide in
methanol) for 10 minutes. Primary antibodies [monoclonal mouse
anti CD4 antibody (ZYMED, CA, USA.), monoclonal mouse anti
CD8 antibody (DAKO, CA, USA) and antihuman P53 protein
(DAKO, CA, USA)] was added and incubated for 30 minutes.
The slides were washed and secondary antibody was applied for
30 minutes. HRP (horse radish peroxidase enzyme polymer) reagent
was applied for 30 minutes and the slides were washed in
wash buffer for 5 minutes (two times). Di-acetyl bromo acetic
acid (DAB) was added to the slide for 3-4 minutes and washed
with buffer. The slides were dipped in Mayor’s hematoxylin for
less than a minute and washed in running tap water. Finally, the
slides were dehydrated in ascending grades of alcohol and then
to xylene. Mountex (Histolab AB, Gothenburg, Sweden) was
used to permanently mount slides. Sections from tonsils served
as positive controls, while omission of primary antibodies served
as negative controls.
Immunohistochemical Staining Evaluation: All the slides
were evaluated with an optical microscope Olympus B × 41
(Olympus, Tokyo, Japan) by two independent pathologists who
were unaware of the clinical characteristics of the samples. Evaluation
of immunohistochemical expression of CD4, CD8 and P53
was performed as follows: Five microscopic fields were randomly
selected, and the percentage of the stained cells (cytoplasmic or
nuclear staining) were evaluated. All histopathological and immunohistochemical
samples included were categorized in to three
groups such as normal oral mucosa (normal control) group, oral
epithelial dysplasia group and OSCC group. The parameters used
to analyze the expression of P53 protein and CD4, CD8, are: 1)
pattern of distribution of positive cells in the epithelial layers and
sub-epithelial stroma in cases of epithelial dysplasia and at the
tumor invasion front (neoplastic nests and peritumoral stroma)in
cases of OSCC, 2) the percentage of positive cells. The staining
intensity was graded upon microscopic examination based on the
number of positive cells using a 3-grade scoring: 0 (No staining
cells), 1 (week staining=if the positive cells comprised less than
20%), 2 (moderate staining = positive cells :20-50%), 3 (strong
staining = positive cells more than 50%).
Statistical Analysis
The statistical analysis was performed using SPSS software version
20. Frequencies were calculated and chi square test was performed
to compare between the frequencies. Multiple regression
and odds ratio were calculated. P value equal or less than 0.05 was
considered significance.
Results
This was a case control study designed to evaluate immunohistochemically
the over expression of P53 in cases of oral epithelial dysplasia and oral squamous cell carcinoma and correlated it with
the expression of the immune cell in?ltrate (CD4 and CD8) in
the same lesions, in addition to evaluate the risk factors related to
oral epithelial dysplasia and oral squamous cell carcinoma. A total
of (300) patients (240) as control and (60) as cases were included
in this study, all cases and controls answer the questionnaire and
subjective to oral examinations. For histopathological examinations,
all the cases were examinedwhile a randomly selected (60)
participants from the control group matched with the cases were
included. The lesions sitesamong epithelial dysplasia and OSCC
patients were explained in graph (1) where the histopathological
tissues were collected, gingival tissue samples were collected from
the (60) participants in control group. Among the OSCC patients
the stages of tumor and the histopathological differentiation were
mentioned in graph (2).
Graph 1. Percentages of oral sites distribution of epithelial dysplasia and oral squamous cell carcinoma lesions.
Graph 2. Percentages of clinical stages and histological differentiation of the oral squamous cell carcinoma (OSCC) patients.
Regarding the demographic characters for the cases and control groups, the percentages of males and females in the control and cases groups were equally with no significance difference between the three groups (p = 0.09). The age distribution among the control and cases groups showed no significance difference (p = 0.125). Educational level was varying from low to high level, control group showed high percent (29.6%) of high educational level compared with (14.3%) among OSCC, no significance difference was found (p = 0.06). Using of teeth brush was notice with high percentages for twice or more than twice daily (42.5% and 39.2% respectively) among control group. On the other hand, epithelial dysplasia group showed high percentages of no brush usage or use it once (56% and 28% respectively) which was similar to that among OSCC group (77.1% and 17.1%). Significant difference was found (p < 0.000) between the three groups regarding the teeth brushing number per day. Regarding the periodontal conditions, mild and moderate periodontitis were observed with high percentages (63.8% and 31.3% respectively) among control group. Mild periodontitis was not observed among cases with epithelial dysplasia and OSCC while, sever periodontitis and tooth mobility were recorded with high percentages (56%, 36%, 65.7% and 34.3%) among epithelial dysplasia and OSCC groups. Significance difference was found (p < 0.000). By evaluation the presence of prosthodontic appliances, only 12% and 14.2 % from cases with epithelial dysplasia and OSCC had no appliances, compared with (82.5%) among the control cases. Significant difference was found (p < 0.000). Among cases (52% and 48.7%) were recorded as current smoking more than 10 years, on the other hand (70.8%) of the control group was non-smokers, significant difference was found between them (p < 0.000). Number of cigarette packs consumed per day was very high (64% and 62.9%) among cases with epithelial dysplasia and OSCC respectively with significance difference (p < 0.000) between them and control group (11.7%). (Table 1).
Table 1. Demographic characters, oral conditions, smoking status and duration among cases and control patients.
Table (2) showing the multiple logistic regression model with adjusted odds ratio, it had been showed that current smokers in addition to increasing the number of smoking frequencies per day had high risk to epithelial dysplasia or OSCC than non-smokers (p < 0.000). Non using oral hygiene practice considered one of major risk factor to oral cancer (p < 0.000). Tooth mobility to health (5.9:1) ratio and sever periodontitis (3.8:1) which were considered risk factors to epithelial dysplasia or OSCC. Males showed high risk epithelial dysplasia or OSCC than females (1:1.9), with significant p value (0.05). Low educational level considered risk factor (p value = 0.01) while presence of prosthodontic appliance had no relation to epithelial dysplasia or OSCC formation p value (0.09). Increasing in age had no effect on oral cancer (p value= 0.09).
Table 2. The multiple logistic regression models of different variables, Odds Ratio (OR), 95% confidence interval and pvalues.
Table (3 and 4), showing the staining intensity expressed as (weak, moderate and high) and their distribution in the tissue. P53 immunostaining was evaluated in normal oral mucosa collected from control group, there was a weak expression (100 %) of P35 which localized in the basal layer among (20%), basal and para basal layers among (80%) of them (figure1). Regarding the cases of epithelial dysplasia, it was observed that the nuclear expression of P53 was localized to basal (28%) basal plus parabasal layers of oral epithelium (72%). There was a correlation of P53 expression with dysplasia’s histological grade. In mild and moderate dysplasia cases, there was a weak expression (60%). Moreover, in severe dysplasia, there was strong nuclear expression (40%) with no record for moderate expression (figure 2). As regard to OSCC, all cases (100%) showed strong immune-positive reaction to P53, strong nuclear staining were observed in cancer nests of moderately and well-differentiated OSCC mostly in the peripheral cells and localized in the individually scattered epithelial cells of poorly differentiated OSCC (figure3). Significant difference was found between the control group and epithelial dysplasia and OSCC group (p < 0.000).
Table 3. Staining intensity of P53, CD4 and CD8 among control group, epithelial dysplasia and OSCC cases.
Table 4. Staining distribution of p53, CD4 and CD8 among control group, epithelial dysplasia and OSCC cases.
Regarding CD4 immunostaining evaluation (figures 4,5), the normal mucosa among the control group showed weak expression of CD4 positive cells in the subepithelial stroma (100%). On the other hand, among epithelial dysplasia cases, T cells formed a subepithelial in?ltrate by (100%)which varied from moderate (52%) to strong and (48%) increase with the severity of epithelial dysplasia. In OSCC, CD4 positive cells were present (100%) in the stroma surrounded by the tumor tissue and were signi?cantly more abundant in comparison with epithelial dysplasia. The CD4 staining were expressed by (11.4% weak, 11.4% moderate and 77.2% was strong). Significant difference was found between staining intensity among control and cases of epithelial dysplasia and OSCC (p < 0.000) regarding CD4 expression.
By evaluating CD8 immunostaining, CD8 positive cells showed weak distribution (100%) in subepithelial stroma of normal tissue in control group. Among the epithelial dysplasia cases the intensity was ranged from weak expression (12%), moderate (32%) and high (56%) for CD8 with (100%) distribution in subepithelial stroma. Similarly, the cases of OSCC expressed by (100%) positive CD8 in subepithelial stroma surrounding the tumor with only moderate (62.6%) and strong (37.1%) expression of CD8 positive cells (figure6). Significance difference between control group, epithelial dysplasia and OSCC regarding CD8 expression was found (p =0.01).
Discussion
The present study was designed as a case-control study which able
to study rare diseases using a small number of individuals and
have some logistical advantages over clinical trials or cohort study.
The number of control group was increased by four ratios than
the cases to increase the statistical confidence.
The results of this study showed that males were significant higher
risk to develop OSCC than females (OR1.9), this was explained
by the effect of other related risk factors to oral cancer as smoking
and oral hygiene habits which were evident among males [2,
3, 17]. The present study showed no significant relation of OSCC
with the selected age group. This may be explained by the study’s
selection of agegroups was from 40 years and above, as this age
range was reported in most studies as age related factor to develop
OSCC [18, 19]. Low educational level showed higher significant
association to OSCC compared with those reported with moderate
and high educational level. These may attribute to the indirect
relation between educational level and patient oral hygiene status
or the awareness to early signs detection of oral cancer [20, 21].
The present study showed that smoking was major risk factor
to OSCC by 10.5 folders than non-smokers and the duration of
smoking affect the high frequency of oral cancer. Studies had
been proven that the use of tobacco is associated with the development
of OSCC. Tobacco can cause epigenetic alteration of
oral epithelial cells, inhibit multiple systemic immune functions of
the host and its toxic metabolites might cause oxidative stress on
tissues which induce OSCC [2, 4, 20]. Bad oral hygiene showed
significant association with OSCC (OR 4.3) folder than that with
good oral hygiene (p < 0.000). Many studies showed association
between irregular tooth brushing and oral cancer [2, 5]. Presence
of prosthodontic appliance showed no significance association
with OSCC was observed in the present study which coincidence
with other studies [3, 21]. The risk of OSCC was statistically significantly
higher among patients either with tooth mobility or
sever periodontitis of (OR 5.9, 3.8) compared with patients with
moderate or mild periodontitis.
The concept of cancer immuno editing provides a chance to view
the dynamic interaction between the immune system and dysplastic
cells/tumor cells, with phases of elimination, equilibrium
and escape [22]. The role of immune response in premalignant
disorders is not so well clarified [23]. The immune system has
the capacity to eliminate cells with DNA damage; which have the
potential to undergo malignant transformation, in the early phase
of cell dysplasia or early tumor cell formation [23].
In this study, the general ?nding was that severe pathological
changes in epithelial tissues (moderate and severe dysplasia or
OSCC) are accompanied by a higher level of the immune in?ltrate
of CD4+&CD8+ when compared to lesions with mild dysplasia
and among control group.
There was a significantly increased level of theimmune in?ltrate
of CD4 + cells in OSCC group as compared to epithelial dysplasia
and control group, confirmed by the association between
in?ammatory mononuclear cell in?ltrates and oral premalignant
lesions or OSCC [24]. Other studies revealed that CD4 positive
cells increased in number when the lesion became malignant as
compared to normal mucosa and dysplastic lesions [25, 26].
The results of the present studyshowed that the level of CD8+
cells in OSCC were higher than CD8+ cells in dysplastic lesionsand
controls, which might indicate that the cytotoxic response
was increased in the malignant state. These results were consistent
withthe results of Gannot et.al 2002, which revealed that in
the tongue lesions, the changes in the epithelium from normal
appearance were accompanied by a corresponding increase in the
infiltration of CD4, CD8, CD14, CD19+20, and HLA/DR positive
cells [27]. On the other hand, Rita et.al (1996) examined head
and neck cancers for immune inhibitory factors and found that
IL-10, together with TGF-b and prostaglandins, were associated
with a reduced content of CD8+ cells [28].
The finding of the present study could be explained by previous
report in which CD8+ cells in OSCC were higher than CD8+
cells in dysplastic lesions and controls. Kumagai et.al [29] explained
that the action of cytotoxic CD8+cells in the immune
responses could inhibit the aggressiveness of malignant cells
and that the CD8+cells can recognize and kill potentially malignant
cells. In this respect, some studies considered the increased
amount of CD8+cells as an independent favorable prognostic factor in different types of cancer [30-32]. p53 functions as a
key tumor suppressor as it plays an important role in apoptosis,
genomic stability, and inhibition of angiogenesis. In this study,
thelesions with the OSCC phenotype showed a higher expression
of P53 when compared to epithelial dysplasia group. In normal
oral epithelium, p53 expression was weak in the basal and parabasal
cell layers. There was a correlation of P53 expression with
dysplasia’s histological grade. Significant difference was noticed
between severe dysplasia and the other two types of dysplasia. In
addition, a significant increase of P53 expression of the epithelial
cells in OSCC compared to ED was noted. Immuno expression
of P53 in transformed oral epithelium may be prognostic risk
factor of malignant disorders independent ondysplastic changes,
however, further studies with follow up are important to confirm
this presumption.
Our results were in accordance to previousstudies which suggested
that the immunolocalization of P53 protein may occur at
the very early stages of development of OSCC [33, 34]. A study
by Cruz et.al. revealed that suprabasal P53 immuno expression
patterns are associated with high grades of dysplasia and correlate
with progress to oral squamous cell carcinoma. The authors concluded
that the expression pattern should be considered a marker
for prediction of the malignant transformation, although malignant
transformation also may occurin the absence of suprabasal
p53 expression or dysplastic changes [35]. In this study, there was
no significant relationship between the intensity P53 expression
and the different grades of OSCC, This finding was confirmed
by the previous studies which report no relation between P53 immuno
expression with the differentiation grade of OSCC [36, 37].
Generally, the study results showed that increase p53 expression
is significantly correlated with the expression of CD4 and CD8 in
the epithelial dysplastic lesions and OSCC. The coincidence with
the finding of other studywhich had focused on the increase in
CD8 cytotoxic T cell in response to p53. The CD8 cytotoxic T
cell have been shown to recognize and kill a variety of tumor cell
lines including SCC lines [38]. On the other hand, CD4 T cells
from normal individuals and cancer patients have been shown
to recognize peptides derived from the core domain of p53 [39].
CD4 T cells infiltrate the tumors and have been suggested to play
a role in tumor regression [40].
Conclusion
The most detected risk factors related to OSCC were the frequency
and duration of smoking, bad oral hygiene, sever periodontitis
and low educational level. Public awareness is needed
among these targeted groups to prevent oral cancer. The increase
in theexpression of CD4+, CD8 +with epithelial transformation
from normal to dysplastic or squamous cell carcinoma and its
correlation with the overexpression of P53 may have a potential
significant role asbiological markers of malignant transformation
and carcinogenesis, and it could potentially be utilized in the treatment
of oral squamous cell carcinoma.
References
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014 Jan 7;64(1):9-29.
- Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: Etiology and risk factors: A review. J Cancer Res Ther. 2016 Apr-Jun;12(2):458-63. Pubmed PMID: 27461593.
- Marques LA, Eluf-Neto J, Figueiredo RA, Góis-Filho JF, Kowalski LP, Carvalho MB, et al. Oral health, hygiene practices and oral cancer. Rev Saude Publica. 2008 Jun;42(3):471-9. Pubmed PMID: 18470367.
- Balaram P, Sridhar H, Rajkumar T, Vaccarella S, Herrero R, Nandakumar A, et al. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer. 2002 Mar 20;98(3):440-5. Pubmed PMID: 11920597.
- Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3062-8. Pubmed PMID: 18990747.
- Liu SC, Klein-Szanto AJ. Markers of proliferation in normal and leukoplakic oral epithelia. Oral Oncol. 2000 Mar;36(2):145-51. Pubmed PMID: 10745166.
- Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011 Jan;11(1):9-22. Pubmed PMID: 21160525.
- Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, et al. Novel markers for poor prognosis in head and neck cancer. Int J Cancer. 2005 Feb 20;113(5):789-97. Pubmed PMID: 15499618.
- Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005 Apr;5(4):263-74. Pubmed PMID: 15776005.
- Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004 Jan;4(1):11-22. Pubmed PMID: 14708024.
- Bergmann C, Strauss L, Wang Y, Szczepanski MJ, Lang S, Johnson JT, et al. T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease. Clin Cancer Res. 2008 Jun 15;14(12):3706-15. Pubmed PMID: 18559587.
- Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res. 2006 Jan 15;12(2):465-72. Pubmed PMID: 16428488.
- Öhman J, Magnusson B, Telemo E, Jontell M, Hasséus B. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance. Scand J Immunol. 2012 Jul;76(1):39-48. Pubmed PMID: 22469080.
- Costa NL, Gonçalves AS, Souza-Lima NC, Jaime-Paiva LG, Junqueira- Kipnis AP, Silva TA, et al. Distinct expression of perforin and granzyme B in lip and oral cavity squamous cell carcinoma. J Oral Pathol Med. 2011 May;40(5):380-4. Pubmed PMID: 21342273.
- Russell AL. The Periodontal Index. J Periodontol. 1967 Nov- Dec;38(6):Suppl:585-91. Pubmed PMID: 5237681.
- Barnes L, Eveson JW, Sidransky D, Reichart P, editors. Pathology and genetics of head and neck tumours. IARC; 2005.
- Jiang X, Wu J, Wang J, Huang R. Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways. Tob Induc Dis. 2019 Apr 12;17:29. Pubmed PMID: 31582940.
- Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol. 2001 Jul;37(5):401-18. Pubmed PMID: 11377229.
- Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer: a review of global incidence. Oral Dis. 2000 Mar;6(2):65-74. Pubmed PMID: 10702782.
- Franco EL, Kowalski LP, Oliveira BV, Curado MP, Pereira RN, Silva ME, et al. Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer. 1989 Jun 15;43(6):992-1000. Pubmed PMID: 2732011.
- Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med. 2004 Oct;33(9):525-32. Pubmed PMID: 15357672.
- Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol. 2004;22:329-60. Pubmed PMID: 15032581.
- Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006 Oct;6(10):715-27. Pubmed PMID: 16977338.
- Migliorati CA, Migliorati EK, Silverman S Jr, Greenspan D, Greenspan JS. Phenotypic identification of mononuclear cells in oral premalignant lesions and cancer by monoclonal antibodies. J Oral Pathol. 1986 Jul;15(6):352-8. Pubmed PMID: 3093654.
- Hirota J, Ueta E, Osaki T, Ogawa Y. Immunohistologic study of mononuclear cell infiltrates in oral squamous cell carcinomas. Head Neck. 1990 Mar-Apr;12(2):118-25. Pubmed PMID: 2179166.
- Vetto JT, Lum S, Morris A, Sicotte M, Davis J, Lemon M, et al. Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am J Surg. 1997 Sep;174(3):258-65. Pubmed PMID: 9324133.
- Gannot G, Gannot I, Vered H, Buchner A, Keisari Y. Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Br J Cancer. 2002 May 6;86(9):1444-8. Pubmed PMID: 11986779.
- Young MR, Wright MA, Lozano Y, Matthews JP, Benefield J, Prechel MM. Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int J Cancer. 1996 Jul 29;67(3):333-8. Pubmed PMID: 8707405.
- Kumagai K, Hamada Y, Gotoh A, Kobayashi H, Kawaguchi K, Horie A, et al. Evidence for the changes of antitumor immune response during lymph node metastasis in head and neck squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Sep;110(3):341-50. Pubmed PMID: 20598595.
- Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW, et al. High number of intraepithelial CD8+ tumorinfiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res. 2007 Jan 1;67(1):354-61. Pubmed PMID: 17210718.
- Cho Y, Miyamoto M, Kato K, Fukunaga A, Shichinohe T, Kawarada Y, et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res. 2003 Apr 1;63(7):1555-9. Pubmed PMID: 12670904.
- Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006 Sep 29;313(5795):1960-4. Pubmed PMID: 17008531.
- Rowley H, Helliwell TR, Jones AS, Roland NJ, Field EA, Field JK. An immunohistochemical analysis of p53 protein expression in pre-malignant and malignant tissues of the oral cavity. Clin Otolaryngol Allied Sci. 1997 Feb;22(1):23-9. Pubmed PMID: 9088674.
- Slootweg PJ, Koole R, Hordijk GJ. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Eur J Cancer B Oral Oncol. 1994;30B(2):138-41. Pubmed PMID: 8032302.
- Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, et al. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol. 2002 Feb;55(2):98- 104. Pubmed PMID: 11865002.
- de Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med. 2007 Apr;36(4):191-7. Pubmed PMID: 17391296.
- Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol. 2003 Apr;39(3):222-31. Pubmed PMID: 12618194.
- Sharma P, Shen Y, Wen S, Yamada S, Jungbluth AA, Gnjatic S, et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3967- 72. Pubmed PMID: 17360461.
- Fujita H, Senju S, Yokomizo H, Saya H, Ogawa M, Matsushita S, et al. Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms. Eur J Immunol. 1998 Jan;28(1):305-16. Pubmed PMID: 9485210.
- Patel A, Halliday GM, Barnetson RS. CD4+ T lymphocyte infiltration correlates with regression of a UV-induced squamous cell carcinoma. J Dermatol Sci. 1995 Jan;9(1):12-9. Pubmed PMID: 7727352.